| 注册
首页|期刊导航|山东农业科学|中药新药研发中的风险与控制

中药新药研发中的风险与控制

纪晓琳 陈玉文 逯茂洋

山东农业科学Issue(12):125-128,4.
山东农业科学Issue(12):125-128,4.DOI:10.14083/j.issn.1001-4942.2015.12.030

中药新药研发中的风险与控制

Risks and Their Control in New Traditional Chinese Medicine Research and Development

纪晓琳 1陈玉文 1逯茂洋2

作者信息

  • 1. 沈阳药科大学工商管理学院,辽宁 沈阳 110016
  • 2. 中国农业大学,北京 100193
  • 折叠

摘要

Abstract

Using literature survey method,the risks coexisting with the new traditional Chinese medicine research and development (R&D)were analyzed,and some control approaches were put forward in this pa-per.The results showed that five special risks were found during the research and development of new Tradi-tional Chinese medicines,including assessment before set -up project,formulation determination,raw materi-al control,design of manufacture technology and finished product quality control.In conclusion,the risk anal-ysis and control should be conducted on the key links,even throughout the whole process of new traditional Chinese medicine research and development;the risks should be avoided,timely and effectively responded or shifted as soon as possible,and the high risk rate should be reduced scientifically and reasonably in the process of new drug research and development.

关键词

中药/新药研发/风险控制

Key words

Traditional Chinese medicine/New drug research and development/Risk control

分类

化学化工

引用本文复制引用

纪晓琳,陈玉文,逯茂洋..中药新药研发中的风险与控制[J].山东农业科学,2015,(12):125-128,4.

基金项目

科技部“十二五”重大新药创制国家科技重大专项“辽宁省国家重大新药创制综合平台---基于信息管理的新药研发风险控制技术” ()

山东农业科学

OACSTPCD

1001-4942

访问量0
|
下载量0
段落导航相关论文